Natura &Co, the beauty company, has announced its decision to delist from the New York Stock Exchange (NYSE). This move is in line with the company’s long-term strategy to simplify operations. While maintaining its primary listing of common shares on the B3 stock exchange in São Paulo, Natura &Co has deemed the secondary listing on the NYSE less compelling, as the majority of its trading activity is concentrated on the B3 stock exchange.
The NYSE is expected to suspend Natura &Co’s trading around February 9, and the company has clarified that it has no plans to list, quote, or register its ADRs on another securities exchange or quotation medium.
Fabio Barbosa, CEO of Natura &Co, stated, “The planned delisting of Natura &Co from the New York Stock Exchange is consistent with our long-term strategy for the business. This move underscores our continued focus on simplifying our operations to reduce complexity.”
Natura &Co expressed gratitude to investors holding ADRs and looks forward to welcoming them as shareholders on the B3 market. The company emphasizes its commitment to transparency, maintaining high disclosure standards through its listing in Brazil. Notably, Natura &Co recently sold the Body Shop in November and divested luxury beauty brand Aesop to L’Oréal in 2023.
